PMDA — authorised 21 January 2011
- Marketing authorisation holder: Kyowa Hakko Kirin
- Status: approved
PMDA authorised Nplate on 21 January 2011
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 21 January 2011.
Kyowa Hakko Kirin holds the Japanese marketing authorisation.